Carole Colin
About Carole Colin
Carole Colin is a research engineer at the Institute of NeuroPhysiopathology in Marseille, specializing in therapeutic strategies for glioblastoma and the identification of biomarkers in human gliomas. She has extensive academic and research experience, including a doctorate in biology and postdoctoral work at notable institutions.
Current Role at Institute of NeuroPhysiopathology
Carole Colin serves as an Ingénieur de Recherche at the Institute of NeuroPhysiopathology (INP) in Marseille since 2018. In this role, she focuses on developing therapeutic strategies that target glycolipids recognized by the A2B5 antibody in glioblastoma. Her work contributes to advancing understanding and treatment options for this aggressive form of brain cancer.
Previous Experience at Aix-Marseille Université
Prior to her current position, Carole Colin worked at Aix-Marseille Université from 2002 to 2006, where she completed her Doctorat de sciences in Biologie des Eucaryotes. During this period, she was involved in research within the Faculté de médecine, specifically in the Sector Timone, contributing to the academic and scientific community.
Postdoctoral Research at Université Pierre et Marie Curie
Carole Colin undertook postdoctoral research at Université Pierre et Marie Curie from 2006 to 2007. This position was based at Hôpital de la Pitié Salpêtrière, within the INSERM U711 unit. Her work during this time focused on identifying and detecting diagnostic and prognostic biomarkers in human gliomas, enhancing the understanding of tumor biology.
Educational Background
Carole Colin studied at Aix-Marseille Université, where she achieved her Doctorat de sciences in Biologie des Eucaryotes from 2002 to 2006. Additionally, she pursued further education at Université de Montpellier, completing a non-diploma continuing education program in statistics related to life and health sciences from 2012 to 2013. She also attended CEGOS for project management training in 2020.
Research Focus and Contributions
Carole Colin is engaged in the histo-molecular characterization of glial and glioneuronal tumors in both children and adults. Her research aims to improve diagnostic and therapeutic approaches for these types of tumors, contributing to the broader field of neuro-oncology.